MoneyWorks4Me

The company witnessed a 18.72% growth in the revenue at Rs. 800.79 millions for the quarter ended June 2024 as compared to Rs. 674.50 millions during the year-ago period.Net profit for the quarter ended June 2024 increased significantly by 53.64% to Rs. 83.67 millions from Rs. 54.46 millions.Operating profit for the quarter ended June 2024 rose to 176.35 millions as compared to 142.03 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 800.79 674.50 18.72 800.79 674.50 18.72 3071.72 2509.95 22.38
Other Income 2.78 3.96 -29.80 2.78 3.96 -29.80 18.30 29.41 -37.78
PBIDT 176.35 142.03 24.16 176.35 142.03 24.16 684.63 632.29 8.28
Interest 24.78 21.85 13.41 24.78 21.85 13.41 103.87 60.20 72.54
PBDT 151.57 120.18 26.12 151.57 120.18 26.12 509.77 406.80 25.31
Depreciation 40.19 47.79 -15.90 40.19 47.79 -15.90 195.11 149.19 30.78
PBT 111.38 72.39 53.86 111.38 72.39 53.86 314.66 257.61 22.15
TAX 27.71 17.93 54.55 27.71 17.93 54.55 74.83 62.93 18.91
Deferred Tax -0.32 -0.29 10.34 -0.32 -0.29 10.34 -4.37 1.37 -418.98
PAT 83.67 54.46 53.64 83.67 54.46 53.64 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.02 21.06 4.58 22.02 21.06 4.58 22.29 25.19 -11.52
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..